CONSORT recommendations for reporting harms in clinical trials

By  

Inpharma, Vol. 1, Iss. 1467, 2004-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

A Review of: “Interpreting and Reporting Clinical Trials: A Guide to the CONSORT Statement and the Principles of Randomised Controlled Trials, by A. Keech, V. Gebski, and R. Pike (eds.)”

By Simon Steve  

Journal of Biopharmaceutical Statistics, Vol. 18, Iss. 4, 2008-07 ,pp. : 802-804

Taylor & Francis Ltd

Access to resources Recommend Favorite

ADE reporting in clinical trials lacking

By  

Reactions Weekly, Vol. 1, Iss. 1315, 2010-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Quality of patient-reported outcome reporting across cancer randomized controlled trials according to the CONSORT patient-reported outcome extension: A pooled analysis of 557 trials

By Efficace Fabio   Fayers Peter   Pusic Andrea   Cemal Yeliz   Yanagawa Jane   Jacobs Marc   la Sala Andrea   Cafaro Valentina   Whale Katie   Rees Jonathan   Blazeby Jane   Efficace Fabio  

Cancer, Vol. 121, Iss. 18, 2015-09 ,pp. : 3335-3342

Blackwell Publishing

Access to resources Recommend Favorite

On the Justifiability of ACMG Recommendations for Reporting of Incidental Findings in Clinical Exome and Genome Sequencing

By  

THE JOURNAL OF LAW, MEDICINE & ETHICS, Vol. 43, Iss. 1, 2015-03 ,pp. : 134-142

John Wiley & Sons Inc

Access to resources Recommend Favorite